Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $12,800 - $23,212
-200 Reduced 0.57%
35,000 $2.35 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $25.7 Million - $31.5 Million
-225,000 Reduced 86.47%
35,200 $4.88 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $15.3 Million - $25.1 Million
202,500 Added 350.95%
260,200 $32.3 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $2.58 Million - $4.14 Million
-30,000 Reduced 34.21%
57,700 $5.38 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $9.86 Million - $11.5 Million
87,700 New
87,700 $11.3 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $19.8 Million - $28.6 Million
232,900 Added 776.33%
262,900 $29.8 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $2.29 Million - $2.83 Million
30,000 New
30,000 $2.42 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $987,012 - $1.24 Million
7,600 New
7,600 $4.08 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $853,680 - $1.15 Million
-8,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $2.59 Million - $3.45 Million
-32,000 Reduced 80.0%
8,000 $3.42 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.27 Million - $1.57 Million
15,000 Added 60.0%
40,000 $14.4 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $1.17 Million - $1.57 Million
15,000 Added 150.0%
25,000 $9.24 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $626,800 - $1.05 Million
10,000 New
10,000 $4.05 Million
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $8.12 Million - $12.9 Million
-170,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $6.23 Million - $9.74 Million
170,000 New
170,000 $37.2 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.